MYCN and neuroblastoma: Importantly, MRP1 has been shown to regulate tumor response to chemotherapy in MYCN amplified NBs (96), and several other ABC transporters like ABCC3 and ABCC4 that are transcriptionally regulated by MYCN were found to be associated with poor disease prognosis in NB (97).